Skip to main content
logo
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
186.95
-1.32 (-0.70%)
At close: Apr 2, 2026, 4:00 PM EDT
187.25
+0.30 (0.16%)
After-hours: Apr 2, 2026, 4:53 PM EDT

Jazz Pharmaceuticals Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Neuroscience
2.88B2.82B2.75B2.72B2.70B2.66B2.63B2.64B
Neuroscience Growth
6.68%6.01%4.40%3.25%-0.35%-3.68%-5.92%-5.85%
Oncology
1.13B1.08B1.08B1.08B1.11B1.09B1.07B1.04B
Oncology Growth
1.56%-0.93%1.04%3.77%9.47%13.26%15.16%15.23%

Oncology Revenue Breakdown

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Rylaze Enrylaze
402.92M396.25M395.16M402.33M410.85M411.11M417.19M411.05M
Rylaze Enrylaze Growth
-1.93%-3.61%-5.28%-2.12%4.22%10.08%21.95%31.17%
Zepzelca
307.31M295.20M301.75M308.25M320.32M316.00M308.15M297.45M
Zepzelca Growth
-4.06%-6.58%-2.08%3.63%10.63%9.92%10.13%7.09%
Defitellio Defibtrotide
199.39M198.17M212.24M209.55M216.57M210.00M191.91M192.60M
Defitellio Defibtrotide Growth
-7.93%-5.63%10.59%8.80%17.70%20.99%9.48%4.74%
Vyxeos
146.71M165.23M161.96M160.12M162.60M156.26M151.77M142.82M
Vyxeos Growth
-9.77%5.74%6.71%12.11%10.24%19.42%15.78%9.09%
Modeyso
47.57M11.03M------

Neroscience Revenue Breakdown

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Xywav
1.66B1.59B1.55B1.50B1.47B1.41B1.35B1.31B
Xywav Growth
12.48%13.00%14.58%14.67%15.73%15.77%18.46%24.80%
Epidiolex
1.06B1.05B996.07M991.44M972.42M938.00M900.15M855.28M
Epidiolex Growth
8.92%11.63%10.66%15.92%15.02%15.54%13.32%11.45%
Xyrem
146.03M157.54M179.99M206.83M233.82M291.25M358.24M455.83M
Xyrem Growth
-37.54%-45.91%-49.76%-54.63%-58.96%-59.01%-57.42%-52.07%
Sativex
16.28M19.95M19.78M21.55M18.88M18.84M18.88M15.31M
Sativex Growth
-13.77%5.87%4.76%40.80%-4.02%-2.13%5.81%-20.21%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.